WeVote

Bill

Bill

HB 148

Relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.

89th Legislature, 1st Called Session (2025) Introduced by Tom Oliverson

Texas bill proposes reclassifying certain drugs as Schedule IV controlled substances, affecting medical prescribing, criminal penalties, and law enforcement priorities.

Filed
0
WeVote Research Nonpartisan
Bill Summary · HB 148

Legislative bill overview

HB 148 proposes to reclassify certain substances as Schedule IV controlled substances under Texas's controlled substances framework. The bill was filed on July 21, 2025, and is sponsored by Representative Tom Oliverson. Without access to the specific bill text, the exact substances targeted cannot be confirmed, though Schedule IV typically includes drugs like benzodiazepines and tramadol.

Why is this important

Reclassifying substances to Schedule IV affects law enforcement priorities, criminal penalties, medical prescribing practices, and public health policy. The change can influence which substances are available for medical use, how they're regulated, and what criminal consequences result from possession or distribution. Texas's scheduling decisions also reflect broader national trends in drug policy.

Potential points of contention

  • Medical access concerns: Moving substances to Schedule IV may restrict or expand physician prescribing authority depending on which drugs are affected and the direction of change
  • Criminal justice impact: Reclassification alters sentencing guidelines and felony classifications, affecting incarceration rates and criminal records
  • Definitional ambiguity: Without the full bill text, it's unclear which specific substances are targeted and whether the reclassification reflects scientific evidence or political priorities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.